Pardeep Nijhawan insider trades: Edesa Biotech (EDSA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pardeep reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | EDSA | ↑ Buy | 1,000 | $6.60 | $7K | Direct | Mar 10, 2026 (0d) |
| Mar 5, 2026 | EDSA | ↑ Buy | 10,000 | $3.90 | $39K | Held by Pardeep Nijhawan Medicine Profes | Mar 6, 2026 (1d) |
| Mar 4, 2026 | EDSA | ↑ Buy | 10,000 | $4.26 | $43K | Held by Pardeep Nijhawan Medicine Profes | Mar 5, 2026 (1d) |
| Mar 3, 2026 | EDSA | ↑ Buy | 10,000 | $3.63 | $36K | Held by Pardeep Nijhawan Medicine Profes | Mar 4, 2026 (1d) |
| Mar 2, 2026 | EDSA | ↑ Buy | 2,000 | $2.00 | $4K | Direct | Mar 3, 2026 (1d) |
| Mar 2, 2026 | EDSA | ↑ Buy | 1,000 | $2.28 | $2K | Held by Pardeep Nijhawan Medicine Profes | Mar 3, 2026 (1d) |
| Feb 27, 2026 | EDSA | ↑ Buy | 30,000 | $2.22 | $67K | Held by Pardeep Nijhawan Medicine Profes | Mar 2, 2026 (3d) |
| Feb 26, 2026 | EDSA | ↑ Buy | 20,571 | $1.58 | $32K | Direct | Mar 2, 2026 (4d) |
| Mar 25, 2024 | EDSA | ↑ Buy | 5,000 | $4.00 | $20K | Held by Pardeep Nijhawan Medicine Profes | Mar 25, 2024 (0d) |
| Jun 30, 2022 | EDSA | ↑ Buy | 20,000 | $1.60 | $32K | Direct | Jul 5, 2022 (5d) |
| May 27, 2022 | EDSA | ↑ Buy | 5,000 | $1.92 | $10K | Direct | May 31, 2022 (4d) |
| May 24, 2022 | EDSA | ↑ Buy | 2,000 | $1.80 | $4K | Direct | May 25, 2022 (1d) |
| Mar 31, 2022 | EDSA | ↑ Buy | 2,000 | $2.99 | $6K | Direct | Apr 1, 2022 (1d) |
| Mar 30, 2022 | EDSA | ↑ Buy | 2,000 | $3.05 | $6K | Direct | Mar 31, 2022 (1d) |
| Mar 29, 2022 | EDSA | ↑ Buy | 2,000 | $3.02 | $6K | Direct | Mar 30, 2022 (1d) |
| Mar 18, 2022 | EDSA | ↑ Buy | 2,000 | $3.85 | $8K | Direct | Mar 21, 2022 (3d) |
| Mar 17, 2022 | EDSA | ↑ Buy | 2,000 | $3.26 | $7K | Direct | Mar 18, 2022 (1d) |
| Mar 15, 2022 | EDSA | ↑ Buy | 2,000 | $2.80 | $6K | Direct | Mar 16, 2022 (1d) |
| Mar 11, 2022 | EDSA | ↑ Buy | 7,000 | $3.09 | $22K | Direct | Mar 14, 2022 (3d) |
| Mar 9, 2022 | EDSA | ↑ Buy | 1,500 | $3.05 | $5K | Direct | Mar 10, 2022 (1d) |
| Mar 25, 2021 | EDSA | ↑ Buy | 3,000 | $5.25 | $16K | Direct | Mar 26, 2021 (1d) |
| Mar 24, 2021 | EDSA | ↑ Buy | 5,000 | $5.16 | $26K | Direct | Mar 25, 2021 (1d) |
| May 26, 2020 | EDSA | ↑ Buy | 3,000 | $2.98 | $9K | Held by Pardeep Nijhawan Medicine Profes | May 28, 2020 (2d) |
| Mar 29, 2020 | EDSA | ↑ Buy | 2,000 | $5.23 | $10K | Direct | Mar 29, 2021 (365d) |
| Mar 17, 2020 | EDSA | ↑ Buy | 5,000 | $1.87 | $9K | Held by Pardeep Nijhawan Medicine Profes | Mar 19, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Pardeep Nijhawan's insider trades
Pardeep Nijhawan is Chief Executive Officer at Edesa Biotech (EDSA). Since Mar 17, 2020, Pardeep has reported 25 open-market purchases worth $430K and no sales on SEC Form 4. In the last 12 months: 8 buys ($230K).
Their filings also include grants and awards (48 filings), option exercises (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EDSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.
